SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001235802-08-000032
Filing Date
2008-04-01
Accepted
2008-04-01 16:28:54
Documents
1
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4253
  Complete submission text file 0001235802-08-000032.txt   6181
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address
Business Address 4600 HIGHLANDS PARKWAY SUITE A & B SMYRNA GA 30082 7708059769
ROSENOW EDWARD C III (Reporting) CIK: 0001241294 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 08729754